高齢者の男性における冠動脈疾患に対する歩行の影響:ホノルル・ハート・プログラム
A A Hakim1, J D Curb, H Petrovitch
1Division of Biostatistics and Epidemiology, University of Virginia School of Medicine, Charlottesville, VA, USA.
Circulation
|July 7, 1999
まとめ
毎日1.5マイル以上歩くことは,高齢の男性における冠動脈疾患のリスクを大幅に軽減します. 適度な散歩でさえ,ある程度の保護を提供しており,高齢者のためのアクティブなライフスタイルの利点を強調しています.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 心血管の健康についてです.
- 予防医学は,予防的な医療です.
背景:
- 高齢者の冠動脈疾患 (CHD) リスクに対する歩行の影響は不明である.
- これまでの研究は,歩行習慣と高齢者の心臓病の罹患率や死亡率との明確な関連を確立できませんでした.
研究 の 目的:
- 歩行距離と冠動脈疾患を発症するリスクとの関連を,高齢の男性集団で調査する.
主な方法:
- ホノルル・ハート・プログラムは,身体能力のある高齢者男性 (年齢71~93歳) 2,678人の歩行距離 (マイル/日) を調査した.
- インシデント冠動脈疾患は,2~4年間のフォローアップ期間で追跡されました.
- 統計分析は,歩行距離に基づいて心臓病のリスクを比較した.
主要な成果:
- 1日あたり0.25マイル未満を歩く男性は,1日あたり1.5マイル以上歩いている男性 (5.1%対2.5%) と比較すると,心臓病のリスクが2倍に増加しました.
- また,1日あたり0.25~1.5マイル歩いている人は,最も長い歩行者 (4.5%対2.5%) よりも著しく高い心血管疾患のリスクを示しました.
- これらの関連性は,年齢やその他の心血管疾患のリスク要因を調整した後も依然として有意であった.
結論:
- 歩行距離の増加は,体力のある高齢の男性において冠動脈疾患のリスクの低下と関連しています.
- 高齢者の歩行を奨励することは,心臓血管の健康に重大な利点をもたらす可能性があります.
- 研究結果は,活発なライフスタイルが様々な年齢層の心臓血管の健康に有益であるというより広範な証拠を裏付けています.
関連する概念動画
Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VI: Nursing Management
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


